Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Updated on: June 20,2026

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Updated on:June 20,2026

New study uncovers mechanism explaining how obesity increases cancer risk

by Zen Logsdon,City of Hope National Medical CenterCredit: beyzahzah from PexelsScientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining ex

Updated on: June 16,2026

New study uncovers mechanism explaining how obesity increases cancer risk

by Zen Logsdon,City of Hope National Medical CenterCredit: beyzahzah from PexelsScientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining ex

Updated on:June 16,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on: June 18,2026

Study finds 10-plus genetic markers tied to early follicular lymphoma relapse

byUniversity of MissouriFollicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rat

Updated on:June 18,2026

Single-drug treatments are giving way to combination therapy for lung cancer

by Kathy Katella,Yale UniversityCredit: Unsplash/CC0 Public DomainCombination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means tr

Updated on: June 19,2026

Single-drug treatments are giving way to combination therapy for lung cancer

by Kathy Katella,Yale UniversityCredit: Unsplash/CC0 Public DomainCombination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means tr

Updated on:June 19,2026

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Updated on: June 16,2026

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

by Denise Heady,University of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehe

Updated on:June 16,2026

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de

Updated on: June 19,2026

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de

Updated on:June 19,2026

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

Updated on: July 02,2026

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

Updated on:July 02,2026

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

Updated on: July 06,2026

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

Updated on:July 06,2026

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

Updated on: July 10,2026

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

Updated on:July 10,2026